UK markets close in 5 hours 4 minutes

Celldex Therapeutics, Inc. (CLDX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
51.88+3.82 (+7.95%)
At close: 04:00PM EST
55.00 +3.12 (+6.01%)
Pre-market: 06:07AM EST
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
6,883
6,883
2,357
4,651
7,418
Operating expenses
Research development
118,011
118,011
82,258
53,311
42,534
Selling general and administrative
30,914
30,914
27,195
20,488
14,456
Total operating expenses
148,925
148,925
109,453
73,799
56,990
Operating income or loss
-142,042
-142,042
-107,096
-69,148
-49,572
Total other income/expenses net
613
613
-5,229
-1,590
-11,375
Income before tax
-141,429
-141,429
-112,325
-70,738
-60,947
Income tax expense
0
0
0
-227
-1,167
Income from continuing operations
-141,429
-141,429
-112,325
-70,511
-59,780
Net income
-141,429
-141,429
-112,325
-70,511
-59,780
Net income available to common shareholders
-141,429
-141,429
-112,325
-70,511
-59,780
Basic EPS
-1.64
-2.92
-2.40
-1.64
-2.02
Diluted EPS
-1.64
-2.92
-2.40
-1.64
-2.02
Basic average shares
42,870
48,449
46,888
42,870
29,640
Diluted average shares
42,870
48,449
46,888
42,870
29,640